Moroccan professor Adnane Remmal has received the 2026 UNESCO–Equatorial Guinea International Prize for Research in the Life Sciences. He is one of three scientists selected for the distinction this year. The international recognition highlights research conducted in Morocco on a major health challenge while giving greater visibility to the contribution of Moroccan science within a multilateral framework.
The award ceremony took place on November 6, 2026, at UNESCO Headquarters in Paris. It marked the tenth edition of this international distinction devoted to research in the life sciences. Remmal’s inclusion among the laureates underlines the international significance attributed to his work and provides a constructive example of the reach achieved by research developed within a Moroccan university.
Research addressing antimicrobial resistance
A professor at Sidi Mohamed Ben Abdellah University in Fez, Adnane Remmal was honoured for pioneering research addressing antimicrobial resistance. This scientific focus is central to the recognition announced by UNESCO. The prize therefore distinguishes an approach developed at a Moroccan university and directed towards a challenge with direct implications for human health, without suggesting that the broader problem has been resolved.
His research led to the development of OLIPEN, which combines an antibiotic with an essential-oil component. The verified sources state that the treatment has been approved for clinical use in Morocco. They present it as offering therapeutic prospects for patients in the country with multidrug-resistant infections, but do not establish that it is effective for every infection falling within that broad category.
Connecting human and animal health
The recognized work extends beyond human health. Remmal has also developed natural alternatives to antibiotics for livestock, seeking to reduce antibiotic use in farming. This dimension connects human and animal health concerns and shows that his research addresses antibiotic use across complementary fields. It is a significant part of the scientific contribution described in the material supporting the 2026 award.
The available evidence supports the stated objective of reducing antibiotic use in livestock and the connection established between human and animal health. It does not support adding numerical outcomes, comparative efficacy data or commercial details about these alternatives. Any such assessment would require separate scientific, clinical or regulatory documentation. The award should therefore be presented within the precise boundaries of the information verified by the cited institutions.
Three laureates selected for 2026
Adnane Remmal shares the 2026 prize with Chinese neuroscientist Nancy Yuk-yu Ip and Spanish microbiologist Carlos Martín Montañés. This group places the Moroccan professor alongside researchers working in other scientific environments. His selection consequently situates research from a Moroccan university within an international group recognized for contributions to the life sciences, reinforcing the constructive global visibility created by the distinction.
The three laureates share a total award of USD 300,000. Each also receives an “Integración Tribal” statuette created by Equatorial Guinean artist Leandro Mbomio Nsue. These details define the terms of the 2026 edition. The verified material establishes that the monetary award is shared by the three scientists, but does not provide grounds for describing any different individual allocation.
A prize supporting research and sustainable development
The UNESCO–Equatorial Guinea International Prize for Research in the Life Sciences was established by UNESCO’s Executive Board in 2008 and is funded by the Republic of Equatorial Guinea. It recognizes scientific research that contributes to improving the quality of human life and supports sustainable development. This institutional purpose provides the wider context for the distinction awarded to Adnane Remmal and the other laureates.
The 2026 laureates were selected by an international jury of five scientists chaired by Moroccan physicist Rajaâ Cherkaoui El Moursli. Her role as jury chair is separate from the recognition received by Remmal, but it represents another Moroccan contribution to the international scientific process surrounding the prize. Together, these verified elements show Moroccan expertise represented in distinct capacities during the tenth edition.
Understanding the distinction with precision
The award confirms UNESCO’s recognition of the pioneering nature of Remmal’s research addressing antimicrobial resistance and of the therapeutic prospects associated with OLIPEN for patients in Morocco. It does not mean that antimicrobial resistance has been solved. Nor does the verified evidence establish that the treatment is suitable for every multidrug-resistant infection or clinically superior to other therapeutic options that may be used.
The sources state that OLIPEN has been approved for clinical use in Morocco, but they do not establish its current retail availability, prescribing conditions, price or regulatory authorization number. Those details remain to be confirmed through a competent Moroccan authority or documented clinical and regulatory evidence. Within these clearly defined limits, the 2026 prize constitutes substantial international recognition for Moroccan university research and its practical health focus.
